Basit öğe kaydını göster

dc.contributor.authorDecristoforo, Clemens
dc.contributor.authorOcak, Meltem
dc.contributor.authorKremser, Leopold
dc.contributor.authorKabasakal, Levent
dc.contributor.authorOzsoy, Y.
dc.contributor.authorHelbok, Anna
dc.contributor.authorvon Guggenberg, Elisabeth
dc.date.accessioned2021-03-06T09:33:28Z
dc.date.available2021-03-06T09:33:28Z
dc.date.issued2011
dc.identifier.citationOcak M., Helbok A., von Guggenberg E., Ozsoy Y., Kabasakal L., Kremser L., Decristoforo C., "Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative", Nuclear Medicine and Biology, cilt.38, ss.171-179, 2011
dc.identifier.issn0969-8051
dc.identifier.othervv_1032021
dc.identifier.otherav_e616c51b-6748-4b03-955e-acc09d27011e
dc.identifier.urihttp://hdl.handle.net/20.500.12627/151360
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79551680701&origin=inward
dc.identifier.urihttps://doi.org/10.1016/j.nucmedbio.2010.07.009
dc.description.abstractIntroduction: Lack of correlation between in vitro and in vivo stability is a general problem for the development of radiopeptides especially in the case of minigastrin derivatives for therapeutic applications. In this study, we compared the influence of experimental conditions on radiopeptide stability results in vitro using a model Minigastrin (MG) analogue labelled with Lu-177. Additionally, we attempted to characterize the main serum enzymatic cleavage sites by matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS) analysis.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectNükleer Tıp
dc.subjectDahili Tıp Bilimleri
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.titleInfluence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative
dc.typeMakale
dc.relation.journalNuclear Medicine and Biology
dc.contributor.departmentMedical University of Innsbruck , ,
dc.identifier.volume38
dc.identifier.issue2
dc.identifier.startpage171
dc.identifier.endpage179
dc.contributor.firstauthorID36997


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster